GTC Biotherapeutics (fka GTCB)

[read_this_n0w]

Well dew, if they did do financing, they should combine it with R/S same day or something and than combine it with strong PR items on Atryn data and timeline.

Thus the company would eliminate futher investor uncertainty later this year should market conditions stay tricky and thus possibility for share price to linge.

Buyout would piss me off, since low price now would all be due to management choices in the past, mainly to be development partner and burn cash for future prospects, opposed to being more production minded in return for short term cash.

All past management choices have been towards the former.
A buyout now would make them libel for mismanagement i would say.


They could allways try to amend the LFB limit of 19.9% and they could place any amount they would, but that too would hurt current holders, would give a trca scenario... ie buyout later on on relative good premium.. on a beaten down price.

PS you know i do not dismiss any fob items, not for gtcb either, although phase I is stronger show of potency for those.
But lets not redo that debate here